The new series of data not only revises the base year for calculation purposes to 2022-23, it also incorporates several vital changes with an aim to give a more accurate measurement of the size of the ...
13h
India GDP Q3 Growth Data 2026 Highlights: Real GDP grows at 7.8% in first GDP data under new series
The GDP data for Q3 FY 2025-26 was released today at 4:00 PM by the Ministry of Statistics and Programme Implementation (MoSPI). This is the first GDP data set that has been released as per the new ...
Real-world data (RWD) is transforming clinical research, augmenting existing randomized controlled trial (RCT) data to de-risk studies and improve generalizability. With regulators setting clearer ...
India will announce its Q3FY26 GDP data tomorrow, marking the debut of a new GDP series with FY23 as the base year, and while ...
Gross Domestic Product or GDP, is a way to measure the size and health of a country’s economy, more like a report card for a nation, it tells us how much the country is producing in terms of goods and ...
Newly collected data on publicly-listed companies in the G7 suggest governance of US firms may be less globally adept than their foreign rivals.
Wall Street will look to build on a dramatic Friday turnaround that saw the Dow Jones Industrial (^DJI) close above 50,000 for the first time, while a 2% daily rally in the S&P 500 (^GSPC) and Nasdaq ...
The Ministry of Statistics and Programme Implementation (MoSPI) has officially shifted India's GDP base year to 2022-23.
In November, Charlotte, N.C.-based Advocate Health launched a systemwide clinical trial network. The Advocate Health National Center for Clinical Trials aims to make clinical research part of routine ...
After a decade, the GDP series is undergoing a revision. Some of the proposed changes will make for a more accurate reading of the economy but the shortcomings of the deflator will remain ...
A 1 Gw orbital data center would cost roughly $42.4B—almost three times its ground-bound equivalent.
DigitalOcean Holdings, Inc. has accelerated top-line growth, benefiting from generative AI demand & winning AI-native customers. Read more on DOCN stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results